Orexigen Therapeutics

Orexigen Therapeutics company information, Employees & Contact Information

Orexigen’s commitment to patients is reflected in all that we do: we are a company driven by the knowledge that our work is important and the desire to make a difference. Orexigen offers prospective employees exciting challenges, unique opportunities for career growth, and a fast-paced environment that emphasizes innovation and achievement.

Company Details

Employees
46
Address
3344 North Torrey Pines Court,
Phone
(858) 875-8600
Email
in****@****gen.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
La Jolla, CA
Looking for a particular Orexigen Therapeutics employee's phone or email?

Orexigen Therapeutics Questions

News

No magic pill for obesity: Orexigen files for bankruptcy - BioPharma Dive

No magic pill for obesity: Orexigen files for bankruptcy BioPharma Dive

Orexigen's post-Takeda plans for Contrave don't include 2016 growth - Fierce Pharma

Orexigen's post-Takeda plans for Contrave don't include 2016 growth Fierce Pharma

Orexigen Enters into Agreement to Sell Company to Newly Formed Entity Nalpropion Pharmaceuticals - BioSpace

Orexigen Enters into Agreement to Sell Company to Newly Formed Entity Nalpropion Pharmaceuticals BioSpace

Time’s a-ticking for bankrupt Orexigen to sell off Contrave - Fierce Biotech

Time’s a-ticking for bankrupt Orexigen to sell off Contrave Fierce Biotech

EX-99.1 - SEC.gov

EX-99.1 SEC.gov

Third Circuit Axes Triangular Setoffs in Bankruptcy | Publications | Insights - Faegre Drinker Biddle & Reath LLP

Third Circuit Axes Triangular Setoffs in Bankruptcy | Publications | Insights Faegre Drinker Biddle & Reath LLP

LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue - ScienceDirect.com

LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue ScienceDirect.com

In Khoja, the Ninth Circuit Limits Defendants’ Ability to Argue Facts in a Motion to Dismiss - Mintz

In Khoja, the Ninth Circuit Limits Defendants’ Ability to Argue Facts in a Motion to Dismiss Mintz

Cleveland Clinic embroiled in drug trial scandal - Healthcare Dive

Cleveland Clinic embroiled in drug trial scandal Healthcare Dive

Orexigen’s Cardiovascular Outcomes Trial for Contrave, the Light Study, Is Enrolling Faster Than Expected - Making Sense of Diabetes

Orexigen’s Cardiovascular Outcomes Trial for Contrave, the Light Study, Is Enrolling Faster Than Expected Making Sense of Diabetes

The FDA Just Approved A New Diet Pill With Expected Sales Of $200 Million In 2016 — But There's A Catch - businessinsider.com

The FDA Just Approved A New Diet Pill With Expected Sales Of $200 Million In 2016 — But There's A Catch businessinsider.com

Valeant Canada Announces Health Canada Approval of CONTRAVE® - MultiVu

Valeant Canada Announces Health Canada Approval of CONTRAVE® MultiVu

Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus - Nature

Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus Nature

Orexigen agrees to sale, but is open to more offers - BioPharma Dive

Orexigen agrees to sale, but is open to more offers BioPharma Dive

Orexigen’s Weight-Loss Drug Contrave Is Denied FDA Approval - Making Sense of Diabetes

Orexigen’s Weight-Loss Drug Contrave Is Denied FDA Approval Making Sense of Diabetes

Currax launches new Contrave 'One Size Does Not Fit All' campaign, hoping to bolster its weight loss credentials - Fierce Pharma

Currax launches new Contrave 'One Size Does Not Fit All' campaign, hoping to bolster its weight loss credentials Fierce Pharma

Pernix Therapeutics Buys Bankrupt Orexigen’s Weight Loss Drug for $73.5 Million - BioSpace

Pernix Therapeutics Buys Bankrupt Orexigen’s Weight Loss Drug for $73.5 Million BioSpace

Orexigen and Valeant bulk up Contrave deal - BioPharma Dive

Orexigen and Valeant bulk up Contrave deal BioPharma Dive

Valeant acquires Orexigen’s obesity drug, stock continues its slide - BioPharma Dive

Valeant acquires Orexigen’s obesity drug, stock continues its slide BioPharma Dive

Orexigen, Takeda take Actavis to court over obesity med Contrave generic - BioPharma Dive

Orexigen, Takeda take Actavis to court over obesity med Contrave generic BioPharma Dive

Feeding and food availability modulate brain-derived neurotrophic factor, an orexigen with metabolic roles in zebrafish - Nature

Feeding and food availability modulate brain-derived neurotrophic factor, an orexigen with metabolic roles in zebrafish Nature

Seth Klarman Buys Stake in Orexigen Therapeutics - Forbes

Seth Klarman Buys Stake in Orexigen Therapeutics Forbes

Orexigen, seller of weight-loss drug Contrave, agrees to sale for $75 million - San Diego Union-Tribune

Orexigen, seller of weight-loss drug Contrave, agrees to sale for $75 million San Diego Union-Tribune

FDA Approves Orexigen's Weight-Loss Drug - The Wall Street Journal

FDA Approves Orexigen's Weight-Loss Drug The Wall Street Journal

Orexigen Halts Development of Anti-Obesity Therapies - Genetic Engineering and Biotechnology News

Orexigen Halts Development of Anti-Obesity Therapies Genetic Engineering and Biotechnology News

Takeda Shells Out $50M Up Front for Orexigen’s Registrational Obesity Drug - Genetic Engineering and Biotechnology News

Takeda Shells Out $50M Up Front for Orexigen’s Registrational Obesity Drug Genetic Engineering and Biotechnology News

Orexigen Revises Previously Released Study Data Of Obesity Drug - RTTNews

Orexigen Revises Previously Released Study Data Of Obesity Drug RTTNews

Orexigen Stock Plummets with FDA Delaying Approval of Anti-Obesity Therapy Contrave - Genetic Engineering and Biotechnology News

Orexigen Stock Plummets with FDA Delaying Approval of Anti-Obesity Therapy Contrave Genetic Engineering and Biotechnology News

Orexigen’s obesity pill Mysimba set for European approval - PMLiVE

Orexigen’s obesity pill Mysimba set for European approval PMLiVE

Orexigen Weight-Loss Pill Dinged by FDA: What Next for Contrave? - CBS News

Orexigen Weight-Loss Pill Dinged by FDA: What Next for Contrave? CBS News

FDA OKs Orexigen’s weight loss pill - San Diego Union-Tribune

FDA OKs Orexigen’s weight loss pill San Diego Union-Tribune

Top Orexigen Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant